The next evolution of
biomanufacturing

We deliver the next generation of bioprocess technologies by leveraging the strengths of process intensification and chaining

More About Us

Our Products

We design innovative cost-
effective manufacturing solutions

scale-X™ bioreactor

Intensified fixed-bed technology for
cost-effective & scalable viral production

Discover product

NevoLine™ Upstream platform

Integrated & automated solution
for intensified virus manufacturing

Discover product

NevoLine Upstream platform intensified and automated viral production Univercells Technologies

Brochure

Service Offering: scale-X™ carbo bioreactor system

Univercells Technologies provides reliable service solutions and quality support & maintenance to help you maintain performance and maximum safety of the equipment.

Download

Brochure

Intensified & automated biomanufacturing technologies for gene therapies production

The scale-X™ bioreactor range and the NevoLine™ platform: integrated and automated solutions for an intensified AAV and Lentiviral vectors manufacturing.

Download

Application Note

Promising Vero cell growth in scale-X™ bioreactors

Case study comparing adherent Vero cell growth on microcarriers and intensified, fixed-bed scale-X bioreactors hydro (2.4 m²) and carbo (10-30 m²). Results demonstrate the scale-X bioreactors as a suitable alternative to traditional technologies.

Learn more

Our Company

We believe in technology
-driven affordability

Our team

Successfully leading
our innovation

Discover more

Our history

Redefining biomanufacturing for human health

Discover more

WE ARE HIRING

Looking For Your Next Challenge ?

Apply Now

Ology Bioservices scale-X single-use bioreactor vaccine manufacture

CDMO Ology Bioservices adopts the scale-X™ bioreactor to respond to vaccine manufacturing challenges

Ology Bioservices is a full-service Contract Development Manufacturing Organization (CDMO) serving both government and commercial clients, specializing in biologic drug substance manufacturing from early-stage through commercial product. The company is continuously evaluating new […]

Read article